2015
DOI: 10.1016/j.jaci.2014.12.012
|View full text |Cite
|
Sign up to set email alerts
|

Ebola in the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Based on the articles reviewed [1, 9, 14, 15, 18, 23, 26, 31, 36, 38, 45, 5961, 64, 68, 69, 71, 74, 78, 79, 83, 85, 86, 89, 92, 93, 97, 99, 105, 112116] a consensus narrative could be constructed for the EVD outbreak (see Table 2, S1 Table for details). It is important to note that we do not attempt to present the narrative as more than what can be gleaned from the collection of scored review articles.…”
Section: Resultsmentioning
confidence: 99%
“…Based on the articles reviewed [1, 9, 14, 15, 18, 23, 26, 31, 36, 38, 45, 5961, 64, 68, 69, 71, 74, 78, 79, 83, 85, 86, 89, 92, 93, 97, 99, 105, 112116] a consensus narrative could be constructed for the EVD outbreak (see Table 2, S1 Table for details). It is important to note that we do not attempt to present the narrative as more than what can be gleaned from the collection of scored review articles.…”
Section: Resultsmentioning
confidence: 99%
“…In more recent times, the global spread of HIV-1, outbreaks related to avian influenza, and the emergence of severe acute respiratory syndrome and Middle Eastern respiratory syndrome, to name a few, profoundly illustrate how an infection can spread worldwide in a very rapid fashion (Table I). 1 In this issue of the Journal, Kampmann et al 2 and Lindblad et al 3 describe the ongoing Ebola virus disease (EVD) outbreak that is currently ravaging West Africa, and Petidemange et al 4 describe how the immune system might be promoting the viral spread and immunopathology of chikungunya virus (CHIKV) infection.…”
mentioning
confidence: 99%
“…The use of humanized mAbs targeting Ebola virus and convalescent plasma from EVD survivors, as well as new antivirals, are being investigated for the treatment of those with EVD. 3 Three clinical trials are expected to begin in Ebola treatment centers in Guinea and Liberia in early 2015. This has raised many issues regarding optimal clinical trial design and the ethics of not making a potentially lifesaving treatment available immediately.…”
mentioning
confidence: 99%